COVID-19 Project Team: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 52: Line 52:
* [[User:Ifrah Fatima|Ifrah Fatima, M.B.B.S]]
* [[User:Ifrah Fatima|Ifrah Fatima, M.B.B.S]]
*[[User:ShakibaHassanzadeh|Shakiba Hassanzadeh]]
*[[User:ShakibaHassanzadeh|Shakiba Hassanzadeh]]
*Fausat Adogba
*[[User:Fausatadogba|Fausat Adogba]]


'''Nephrologic Disorders of COVID-19 Team Members'''
'''Nephrologic Disorders of COVID-19 Team Members'''
Line 76: Line 76:
'''Pulmonary Disorders and COVID-19 Team Members'''
'''Pulmonary Disorders and COVID-19 Team Members'''
*'''[[User:Sara Mohsin|Sara Mohsin, M.B.B.S.]]'''
*'''[[User:Sara Mohsin|Sara Mohsin, M.B.B.S.]]'''
* Ayesha Farheen Javid
* [[User:AFarheen|Ayesha Farheen Javid]]
* [[User:Usmanaliakbar|Usman Ali Akbar]]
* [[User:Usmanaliakbar|Usman Ali Akbar]]
*[[User:Rina Ghorpade|Rina Ghorpade]]
*[[User:Rina Ghorpade|Rina Ghorpade]]

Revision as of 16:43, 17 June 2020

COVID-19 Project
Introduction
Team
Meetings' Summary
Topics
Ongoing Clinical Trials

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]

Meet The Team

Associate Editor(s)-in-Chief:

  • The name of the leaders are written in bold:

Cardiovascular Disorders of COVID-19 Team Members

Dermatologic Disorders of COVID-19 Team Members

Frequently Asked Inpatient Questions Team Members

Frequently Asked Outpatient Questions Team Members

Gastrointestinal disorders and of COVID-19

Hematologic disorders of COVID-19 Team Members

Nephrologic Disorders of COVID-19 Team Members

Neurologic Disorders and COVID-19 Team Members

Ongoing Clinical Trials of COVID-19 Team Members


Pediatrics and COVID-19

Pulmonary Disorders and COVID-19 Team Members